Drug Trial Radar · NCT06345703
First-into-human Study of NS-136 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Nov 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
76
Planned (sponsor's estimate)
Start
Apr 30, 2024
Primary completion
Nov 2024
Study completion Feb 2025
Sponsor
- Lead sponsor
- NeuShen TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to exlplore the profile of NS-136 in health conditions. The main questions it aims to answer are: * Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen? * What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing regimen?
Conditions
- Healthy Subjects
Interventions
PlaceboDrug
NS-136 matching placebo
NS-136 tabletDrug
Investigational product NS-136
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment-Related Adverse EventsTime frame: for SAD, day 1-7; for MAD, day 1-26, for FE, day1-14
- Main pharmacokinetic parametersTime frame: for SAD, day 1-7; for MAD, day 1-26,
- Main pharmacokinetic parametersTime frame: for SAD, day 1-7; for MAD, day 1-26,
- Main pharmacokinetic parametersTime frame: for SAD, day 1-7; for MAD, day 1-26,
- Main pharmacokinetic parametersTime frame: for SAD, day 1-7; for MAD, day 1-26,
- Main pharmacokinetic parametersTime frame: for SAD, day 1-7; for MAD, day 1-26,
- Main pharmacokinetic parametersTime frame: for SAD, day 1-7; for MAD, day 1-26,
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, Australia · Recruiting
Chengdu Xinhua Hospital
Chengdu, Sichuan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.